Oocyte activation at fertilization is brought about by the testis-specific phospholipase C zeta (PLCZ), owing to its ability to induce oscillations in intracellular Ca 2+ concentration ([Ca 2+ ] i ). Whereas this is a highly conserved mechanism among mammals, important species-specific differences in PLCZ sequence, activity, and expression have been reported. Thus, the objectives of this research were to clone and characterize the intracellular Ca
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-releasing activity and expression of equine PLCZ in sperm and testis. Molecular cloning of equine PLCZ yielded a 1914-bp sequence that translated into a protein of the appropriate size (;73 kDa), as detected with an anti-PLCZspecific antibody. Microinjection of 1 lg/ll of equine PLCZ cRNA supported [Ca 2+ ] i oscillations in murine oocytes that were of a higher relative frequency than those generated by an equivalent concentration of murine Plcz cRNA. Immunofluorescence revealed expression of PLCZ over the acrosome, equatorial segment, and head-midpiece junction; unexpectedly, PLCZ also localized to the principal piece of the flagellum in all epididymal, uncapacitated, and capacitated sperm. Immunostaining over the acrosome was abrogated after induction of acrosomal exocytosis. Moreover, injection of either sperm heads or tails into mouse oocytes showed that PLCZ in both fractions is catalytically active. Immunohistochemistry on equine testis revealed expression as early as the round spermatid stage, and injection of these cells supported [Ca 2+ ] i oscillations in oocytes. In summary, we report that equine PLCZ displays higher intrinsic intracellular Ca 
INTRODUCTION
Oocyte activation at fertilization encompasses the release from metaphase II (MII) arrest, prevention of polyspermy, pronuclear formation, and initiation of embryonic cleavage (for reviews, see [1, 2] ). In all mammalian species studied, this is brought about by repetitive increases in intracytoplasmic Ca 2þ concentration ([Ca 2þ ] i ) [3] [4] [5] [6] [7] , referred to as [Ca 2þ ] i oscillations. Present evidence suggests that the factor responsible for the initiation of these [Ca 2þ ] i oscillations is a testis-specific isoform of phospholipase C (PLC), PLC zeta (PLCZ), which is delivered by the sperm at the time of fertilization [8] . The identity of this protein as a PLC accounts for the findings that cleavage of phosphatidylinositol 4,5-bisphosphate (PIP 2 ) and production of 1,4,5-inositol trisphosphate within the oocyte are required for the initiation and maintenance of the [Ca 2þ ] i oscillations observed at fertilization [9] [10] [11] [12] . PLCZ was first cloned from mouse testis [8] and has since been sequenced in the human, monkey [13] , chicken [14] , pig [15] , medaka fish, rat [16] , and hamster [17] , owing to a highly conserved mechanism for triggering egg activation in mammals and, potentially, other vertebrate species.
Similar in structure to other PLC isoforms, PLCZ spans four EF hand domains at the N terminus, X and Y catalytic domains, and a C2 terminus domain; however, PLCZ lacks the N-terminal plextrin-homology (PH) domain present in other isoforms [18] . Sequence fidelity of the EF hand domains is crucial for the ability of the enzyme to initiate timely [Ca 2þ ] i oscillations within the oocyte [19] , and EF3 is responsible for a 100-fold higher Ca 2þ sensitivity to PIP 2 hydrolysis as compared to other PLC isoforms [20, 21] . Moreover, point mutations in the X catalytic domain of the PLCZ sequence are sufficient to abrogate its intracellular Ca 2þ -releasing activity [19] . Therefore, species-specific differences in PLCZ sequence may be at least partially responsible for the variations in activity and pattern of [Ca 2þ ] i responses observed at fertilization for the different mammalian species studied [8, 13] . For instance, human PLCZ has an approximately 2-to 10-fold higher potency than the simian and mouse counterparts, respectively, in its ability to induce [Ca 2þ ] i oscillations in mouse oocytes [13, 22] . In addition, recent research suggests that the linker region between the X and Y catalytic subunits of the PLCZ protein has important regulatory functions regarding its specific enzymatic activity [19, 23] ; interestingly, this is the least-conserved region of the protein among mammalian species in which PLCZ has been sequenced.
Species-specific differences are also manifested at the level of PLCZ expression and localization in sperm. For instance, PLCZ is immunolocalized to the equatorial region of bull sperm [24] and to the acrosomal and postacrosomal regions of mouse and hamster sperm [17] . Conversely, the majority of human sperm express PLCZ exclusively in the equatorial region, whereas a subpopulation of sperm also shows immunoreactivity over the acrosomal and postacrosomal regions [25] . It is plausible that species variations reflect differences in relative quantity of expression and/or additional functions of PLCZ in sperm physiology. Whereas these assumptions require further investigation, these localizations correspond to regions of the sperm that would facilitate rapid release of PLCZ upon fusion with the oocyte at fertilization.
The sequence and expression pattern of equine PLCZ has not been characterized, but indirect evidence supports the notion that horse sperm possess higher intracellular Ca 2þ -releasing activity than mouse sperm based on the high frequency of [Ca 2þ ] i oscillations observed when injecting horse sperm into mouse oocytes [26] . Additionally, whereas microinjection of 0.5 lg/ll of murine Plcz cRNA into mare oocytes yielded a pattern of [Ca 2þ ] i oscillations similar to that triggered by a single horse sperm, it was unable to support high rates of development to the blastocyst stage (3%-15%) [7, 27] . Previous studies corroborate the notions that the fidelity of the pattern of [Ca 2þ ] i oscillations at fertilization is an important determinant of embryonic development of oocytes [28] and that concentrations of PLCZ cRNA must be optimized to support later stages of in vitro embryonic development [22] . Nonetheless, this also raises the question of whether differences in PLCZ sequence and expression among species may determine the ability of the construct to support later stages of embryonic development. Based upon these premises, the purpose of our study was to clone the sequence of equine PLCZ as well as characterize the expression and localization pattern of catalytically active PLCZ in equine testis and sperm.
MATERIALS AND METHODS

Animals
The use of animals for the present study was performed in compliance with protocols approved by the Institutional Animal Care and Use Committee at Cornell University, College of Veterinary Medicine.
Chemicals and Reagents
Four-Bromo-Calcium Ionophore A23187 was obtained from Calbiochem. Tween 20 was purchased from Bio-Rad. Anti-PLCZ polyclonal antibody, raised in rabbit against the 19-mer sequence (MENKWFLSMVRDDFKGGKI) at the Nterminus of porcine PCLZ (NT-PLCZ), was generously donated by Dr. Rafael Fissore (Department of Veterinary and Animal Sciences, University of Massachusetts, Amherst, MA). PNA-Alexa 488, Hoechst 33258, and Alexa Fluor 555 goat anti-rabbit immunoglobulin (Ig) G were purchased from Invitrogen Corp. Vectashield was purchased from Fisher, Inc. All other chemicals were purchased from Sigma-Aldrich Chemical Company unless otherwise stated.
Molecular Cloning and Sequencing
Fresh testis tissue was obtained from a 23-year-old stallion of proven fertility. Sections of testicular parenchyma were dissected out and either snapfrozen for later use or freshly homogenized for RNA isolation with TRIzol (Invitrogen) following the manufacturer's instructions. One microgram of RNA was subjected to cDNA synthesis reactions using random hexamers from the Cloned AMV First-Strand cDNA Synthesis Kit (Invitrogen), followed by the optional step of RNA denaturation. Complementary DNA was then used as a template for PCR using Platinum Taq DNA Polymerase High Fidelity (Invitrogen) with the following profile: one cycle at 948C for 30 sec; 30 cycles at 948C for 30 sec, 528C for 30 sec, and 728C for 2 min; and one cycle at 728C for 7 min. Specific oligonucleotide primers, 5 0 -TAAGCAAGGAGAAA CAGAACAGCAG-3 0 and 5 0 -CTATCTGACGTACCAAACGT-3 0 (IDT, Inc.), were designed with reference to the bovine PLCZ sequence (GenBank accession no. NM_001011680). Products were separated by electrophoresis on a 1% agarose gel stained with ethidium bromide. The PCR products were extracted and purified using the QIAquick Gel Extraction Kit (Qiagen) and processed using an A-Addition Kit (Qiagen) to modify the blunt-end PCR products before being subcloned into the pGEM-T Easy Vector System I (Promega). Nucleotide sequencing confirmed the equine PLCZ clone. The equine PLCZ clone was compared to PLCZ cDNA from bovine, porcine, and human, as well as to Plcz cDNA from mouse, using MegAlign from the LaserGene package (DNASTAR, Inc.). The equine PLCZ clone was then subcloned into pKH3 plasmid vector containing three HA epitopes cloned upstream of the PLCZ clone. Cloning into this vector facilitated the detection of the PLCZ protein using a commercially available monoclonal antibody against the HA epitope (Roche Applied Science).
In Vitro Protein and cRNA Synthesis
To confirm the size and integrity of the translated gene product, the equine PLCZ cDNA was used as a template in a coupled transcription/translation system using reticulocyte lysates (TnT Coupled Reticulocyte Lysate System; Promega). In some studies, [ 35 S]methionine was incorporated into the synthesis reaction to radiolabel the nascent protein. In these studies, 35 S-labeled proteins (PLCZ and control luciferase proteins) were resolved by SDS-PAGE, and the gels were fixed in 10% acetic acid/methanol. The gels were then washed extensively in distilled water, followed by 20% isopropanol. The gels were then dried, and protein bands were visualized using autoradiography. In other experiments, unlabeled proteins were generated in vitro and incorporated into Western blot analysis using the NT-PLCZ or a mouse monoclonal antibody against the HA epitope, as detailed below.
For microinjection purposes, equine PLCZ and murine Plcz cDNA were transcribed in vitro using the Sp6 mMESSAGE mMACHINE kit (Ambion). The murine Plcz plasmid was kindly provided by Dr. Rafael Fissore. The equine PLCZ cDNA was cloned in a manner identical to that used for the mouse sequence. The cRNA was purified via the MEGAclear kit (Ambion) and NucAway spin columns (Ambion). Concentration of cRNA products was determined spectrophotometrically, and cRNA was stored at À808C in single aliquots at a concentration of 1 lg/ll until use.
Semen Collection and Preparation
Semen was collected with an artificial vagina from six adult (age, 9-23 yr) stallions of proven fertility. The sperm-rich fraction was diluted 2:1 (vol:vol) in prewarmed modified Whitten medium (MW) [29] and washed as previously described [30] . Resulting sperm suspensions were then diluted in MW to a final volume of 10 3 10 6 sperm/ml for capacitation experiments or in PBS at various concentrations for immediate immunoblotting or immunofluorescence experiments (see below).
For experiments requiring separation of sperm heads and tails, washed ejaculates were resuspended in PBS with the addition of a protease inhibitor cocktail and sonicated on ice five times for 2 sec each at 30% amplitude (Sonic Dismembrator 500; Fisher). For immunoblotting, heads and tails were then separated by sequential centrifugation (two times, 100 3 g, 20 min). A suspension of pure tails was obtained from the supernatant after the first centrifugation. The second centrifugation yielded a pellet composed of almost exclusively heads, with less than 1% intact sperm.
For experiments requiring epididymal sperm, the epididymides from three stallions (age, 1-5 yr) were obtained via routine castrations performed at the Cornell University Hospital; the testes from one stallion (age, 23 yr) were obtained postmortem. Epididymides were transported to the laboratory (transport time, ,5 min) in warm PBS. Each epididymal tail was dissected into small pieces and placed into 6 ml of 378C MW for 10 min to allow sperm swim out. Sperm suspensions were washed as described above before processing for immunofluorescence.
Sperm Capacitation and Induction of Acrosomal Exocytosis
For experiments comparing PLCZ immunolocalization in noncapacitated versus capacitated sperm, the sperm collected from three stallions (age, 8-12 yr) were incubated in MW without (noncapacitating) or with (capacitating) the addition of 25 mM NaHCO 3 and 7 mg/ml of bovine serum albumin (BSA; 6 h, 378C, humidified air) as previously described [30] .
To compare the localization of PLCZ before and after acrosomal exocytosis, subsamples of sperm incubated in capacitating conditions were challenged with 5 lM calcium ionophore A23187 for induction of acrosomal exocytosis [30] and processed for immunofluorescence.
SDS-PAGE and Immunoblotting
For identification of PLCZ in fresh sperm samples, sperm, after initial washing, were resuspended in PBS, counted, and aliquoted to final sperm CHARACTERIZATION OF EQUINE PHOSPHOLIPASE C ZETA 79 numbers ranging from 0.05 to 10 3 10 6 sperm; 1 3 10 6 sperm were used for positive control against recombinant PLCZ. Samples were processed for SDS-PAGE and immunoblotting as previously described [30] . For immunodetection, incubation in anti-NT-PLCZ (1:1000 in 5% skim milk) or anti-HA (1:1000 in 5% skim milk) antibodies (overnight at 48C) was followed by incubation in goat anti-rabbit horseradish peroxidase (HRP)-coupled IgG secondary antibody (1:5000 in TBS-Tween 20, 1 h, room temperature). Immunoreactivity was visualized using enhanced chemiluminescence detection with an ECL kit (Amersham Corp.) according to the manufacturer's directions.
Immunofluorescence
Immunofluorescence for localization of PLCZ was performed in epididymal (caput, corpus, and cauda), freshly ejaculated, capacitated, and acrosomereacted sperm. After initial preparation, sperm were washed with PBS by centrifugation (500 3 g, 8 min). The supernatant was discarded, the pellet diluted in fresh PBS, and sperm counted using a hemocytometer. An aliquot was then diluted in PBS at 3 3 10 6 sperm/ml, and 125 ll from this suspension were pipetted onto 0.1% poly-L-lysine-coated slides and allowed to settle for 15 min. Sperm were fixed with 3.7% paraformaldehyde for 30 min at 48C, gently washed three times with 1 ml of PBS, and permeabilized with 0.1% Triton X-100 in PBS for 10 min at room temperature. After gentle washing, sperm were blocked in 5% BSA at 48C in a humidified chamber overnight. The NT-PLCZ antibody (1:100 in blocking buffer) was added to the sperm and again incubated overnight at 48C in a humidified chamber. Negative controls included incubating sperm with either 5 mg/ml of rabbit IgG (in blocking buffer) or antigenic blocked peptide (30 lg of NT-PLCZ peptide preincubated for 2 h with anti-PLCZ antibody in wash buffer) in place of the primary antibody overnight at 48C in a humidified chamber. Sperm were then washed three times with 1 ml of 0.1% Tween 20 in PBS and incubated with Alexa Fluor 555 goat anti-rabbit IgG secondary antibody (1:200 in blocking buffer) for 1 h at room temperature in the dark. Peanut agglutinin-lectin Alexa Fluor 488 HRP conjugate at 20 lg/ml was then added for an additional 1 h, followed by incubation with Hoechst 33258 at 5 lg/ml for 10 min at room temperature in the dark. Slides were washed (0.1% Tween 20 in PBS) and mounted with Vectashield (Vector Laboratories). The next day, slides were analyzed for the pattern of PLCZ localization using an upright fluorescent Zeiss Imager ZI microscope (Carl Zeiss, Inc.) with green fluorescent protein, DAPI, and Texas red filters.
Immunohistochemistry
Fresh testis tissue from three stallions (same group used for PLCZ immunolocalization in epididymal sperm) was obtained via routine castrations (age, 1 and 3 yr) or postmortem (age, 23 yr) at the Cornell University Hospital. Testes were transported to the laboratory (transport time, ,5 min) in warm PBS. Tissue samples were fixed in 4% paraformaldehyde for 24 h before being dehydrated in increasing concentrations of ethanol (30%, 60%, 90%, and 100%). The tissue was then sent to the Cornell University Histology Laboratory in 70% ethanol, embedded in paraffin, and sectioned in chronological order on poly-L-lysine-coated slides. The slides were deparaffinized with xylene, rehydrated with decreasing concentrations of ethanol washes, and then blocked with 0.5% H 2 O 2 in methanol for 10 min. Antigen retrieval was performed using a Zymed kit with ethylenediaminetetra-acetic acid (EDTA) solution (pH 8.0) for heat-induced epitope retrieval (Invitrogen) according to the manufacturer's directions. Briefly, the slides were steamed in 13 EDTA for 5 min in a microwave on high (800 W) and then for 15 min on medium (320 W). Slides were washed with 0.05% Tween 20 in 0.01 M PBS, permeabilized in 0.05% Triton X-100 in 0.01 M PBS for 5 min, and blocked in 10% goat serum with 23 casein (Vector Laboratories) for 20 min at room temperature. Incubation with NT-PLCZ was then performed at a 1:100 dilution in PBS with 13 casein for 1.5 h at 378C. For negative controls, slides were incubated in antigenic peptideblocked NT-PLCZ antibody (as described above) for 1.5 h at 378C. Slides were then incubated in biotinylated goat anti-rabbit IgG secondary antibody (Vector Laboratories) for 20 min (23-258C) at a 1:200 dilution in PBS. Next, the slides were washed with PBS and incubated in streptavidin peroxidase (Invitrogen) for 20 min (23-258C). Visualization of PLCZ localization was achieved using the Aminoethyl Carbazole Substrate Kit (Invitrogen) for approximately 10 min according to the manufacturer's directions. The tissue sections were then counterstained with Gills #2 Hematoxylin (Fisher) for 15 sec at room temperature and mounted with an aqueous mounting medium.
Preparation of Spermatogenic Cell Suspension
Testis tissue from a mature (age, 6 yr) stallion of proven fertility was used to separate spermatogenic cell suspensions following the method described by Joshi et al. [31] . Briefly, small pieces (six pieces, each 5 mm in diameter) of cut testicular parenchyma were placed in 50 ml of BioWhittaker Minimum Essential Medium Eagle (EMEM; Fisher) supplemented with 2 mg/ml of collagenase in an Erlenmeyer flask. The flask was placed in a 338C automated water bath shaking at 130 rpm for approximately 1 h, until dissociation of the seminiferous tubules could be visually observed. The solid suspension of cells was then allowed to settle by gravity and the fluid decanted. In this manner, the suspension was washed three times with 50 ml of EMEM. After the last wash, 0.5 mg/ml of trypsin and 100 ll/ml of DNase I were added, and the flask was returned to the shaking water bath for 15 min. The reaction was then stopped with 0.5 mg/ml of soybean trypsin inhibitor. Next, the suspension was gently pipetted with a large bore (4 mm) plastic pipette to break up any remaining small clumps of tissue and then filtered through an 80-lm nylon screen. The suspension was then centrifuged twice at 450 3 g for 10 min, and the pellet was resuspended with wash buffer (EMEM containing 0.25 mg/ml of soybean trypsin inhibitor and 0.5 lg/ml of DNase); the final 20 ml of resuspended cells were kept at 58C overnight for the first set of injections. Aliquots of cells were also resuspended in 1 ml of 10% dimethyl sulfoxide in EMEM (vol:vol) solution in Eppendorf tubes and snap-frozen by plunging them in liquid nitrogen, with subsequent storage at À1968C. These cells were used in subsequent experiments whereby aliquots were thawed slowly at room temperature, washed twice in EMEM plus 0.5% (wt:vol) BSA, and checked for viability by eosin staining before injection into mouse oocytes.
Preparation of Mouse Oocytes
B6D2F1 or CD1 female mice (Harlan Sprague Dawley, Inc.) were superovulated by injections with 5 IU of equine chorionic gonadotropin (formerly PMSG), followed by injection of 5 IU of human chorionic gonadotropin (hCG) 48 h later (EMD Serono, Inc.). Oocytes were collected 13-14 h after hCG injection, placed into Hepes-buffered tyrode-lactate solution (TL-Hepes) [32] supplemented with 10% fetal calf serum (vol:vol), and denuded in 0.1% porcine hyaluronidase in PBS (wt:vol). Denuded oocytes were then placed into fresh TL-Hepes with 1 lmol/L of Fura 2-acetoxymethylester (Fura 2-AM; Molecular Probes) supplemented with 0.02% pluronic acid (Molecular Probes) at 378C for 20 min. After Fura 2-AM loading, oocytes were placed in warm TL-Hepes and kept at 378C until micromanipulation.
Oocyte Microinjection
Fura 2-AM-loaded mouse (CD1) oocytes were microinjected under an inverted Eclipse TE-200 microscope (Nikon, Inc.) using an Eppendorf Transferman NK-2 (Brinkman Instruments, Inc.) micromanipulators and an Eppendorf Femtojet microinjector (Brinkman Instruments, Inc.). The injection pipette containing medium (control) or 1 lg/ll of equine or murine PLCZ cRNA was advanced into the cytoplasm of each oocyte for microinjection (;10 pl).
Intracytoplasmic Sperm Injection or Round Spermatid Injection
Intracytoplasmic sperm injection (ICSI) or round spermatid injection (ROSI) was performed on MII mouse oocytes (B6D2F1) using sperm heads and tails from two different proven stallions (age, 9 and 18 yr) or round spermatids from a proven stallion (age, 6 yr) that was castrated at the Cornell Hospital for Animals. Injections of sperm or round spermatids were performed using Eppendorf Transferman NK-2 micromanipulators with a piezomicropipette-driving unit (Prime Tech Piezo Impact Drill PMM-150FU; Eppendorf) as previously described [7] . Mock injections were performed by injecting fluid from the sperm head/tail or round cell suspension, which served as a negative control; care was taken that the amount of fluid injected was similar to that injected with an individual sperm head, tail, or round cell. Worth noting is that the injection pipette used had only 6 lm of internal diameter. Therefore, incorporation of a round spermatid within the pipette resulted in its complete disintegration. However, care was taken to inject all components of the cell, which tended to stick together.
Fluorescence Recordings and [Ca 2þ ] i Determination
The [Ca 2þ ] i monitoring was carried out with Fura 2-AM-loaded mouse oocytes after microinjection or ICSI/ROSI as previously described [27] . At least three replicates per experiment were performed. Recording of 340:380 nm fluorescence ratios, which correlate to [Ca 2þ ] i , was performed for 1-2 h.
Statistical Analyses
Data for [Ca þ ] i oscillations (Tables 1 and 2 ) were compared by one-way ANOVA using SigmaStat software. Differences were considered to be significant at P , 0.05.
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RESULTS
Identification and Molecular Cloning of Equine PLCZ
We first determined that immunoblotting of equine sperm using an antibody raised against the N-terminus of the porcine sequence yielded a specific band of the expected molecular size (;73 kDa) (Fig. 1A) , consistent with the expression of equine PLCZ. Interestingly, at levels of sperm for which tubulin was beneath the detectable level of the assay, we could easily observe PLCZ immunoreactivity, potentially suggesting a relative high abundance of the latter in stallion sperm.
The cDNA sequence encoding equine PLCZ yielded a single open-reading frame of 1914 bp encoding for a 638-amino-acid protein (Fig. 2) , with a predicted molecular size of approximately 73 kDa. Multiple ClustalW alignments of the predicted equine amino acid sequence with bovine, porcine, human, and murine PLCZ revealed 79.4%, 82.5%, 82.1%, and 71.9% homology, respectively (Fig. 3) . As suspected, the X-Y linker region (Fig. 2, boxed region) displayed the least regional homology among different species.
In addition, multiple ClustalW sequence alignments with murine and human PLC delta4 (PLCD4; data not shown) also revealed that equine PLCZ lacks the PH domain found at the N-terminus of other PLC isoforms, as previously shown in other mammalian species for this isoform [8, 13, 15] (for review, see [33] ). However, the typical X and Y, C2, and EF hand domains are conserved, as reported for PLCZ in other species (Fig. 2) .
From the cloned sequence, recombinant PLCZ protein was generated using a [
35 S]methionine reticulocyte lysate transcription/translation system. Gel analysis revealed protein bands at approximately 73 kDa for equine and for murine (control) extracts (Fig. 1B) . Moreover, protein resulting from an HAtagged PLCZ sequence was recognized both by antibodies against the HA epitope as well as by the NT-PLCZ antibody (Fig. 1C) . Noteworthy is that this anti-PLCZ antibody does not recognize the murine product. These results support the notion that the sequence cloned herein encodes for equine PLCZ.
Equine PLCZ cRNA Induces [Ca 2þ 
] i Oscillations in Mouse Oocytes
To test the catalytic activity of the equine PLCZ clone, 1 lg/ ll of cRNA was microinjected into mouse oocytes for [Ca 2þ ] i monitoring. The same concentration of murine Plcz cRNA was used as a positive control. As anticipated, equine PLCZ cRNA triggered much higher relative intracellular Ca 2þ -releasing activity than murine Plcz cRNA, as manifested by a higher frequency of [Ca 2þ ] i transients ( Fig. 4 and Table 1 ).
PLCZ Localization in Equine Sperm
Previous studies have shown species-specific differences in the immunolocalization of PLCZ in sperm [17, 24, 25] . Moreover, in some species, PLCZ may undergo redistribution during sperm capacitation and the acrosome reaction [17, 25] . Therefore, we investigated the immunolocalization of PLCZ in all epididymal (head, corpus, and caput), ejaculated, capacitated, and acrosome-reacted stallion sperm. In freshly ejaculated sperm, PLCZ localized to the head region overlying the acrosome, equatorial segment, connecting piece between the head and midpiece, and most interestingly, the principal piece of the flagellum (Fig. 5A ). This localization was specific, because immunoreactivity was not observed in any of these regions in the corresponding control samples (Fig. 5, D-I) . Remarkably, both epididymal and capacitated sperm showed the same pattern of localization as ejaculated sperm (data not shown). However, induction of acrosomal exocytosis did result in loss of PLCZ immunofluorescence over the acrosomal region (Fig. 6A) . These results raise the question of whether PLCZ may play a role in acrosomal exocytosis, as others have suggested [17, 25] . 
CHARACTERIZATION OF EQUINE PHOSPHOLIPASE C ZETA
Because the localization of PLCZ over the sperm flagellum appears to be unique to the stallion as compared to all other species studied to date, we wanted to corroborate the specificity of our immunofluorescence results. In this regard, immunoblotting of both populations of sperm heads and tails separated by sonication revealed a band consistent with the expression of PLCZ (Fig. 6B) . Conversely, immunoreactivity was negative for the supernatant containing the sperm during sonication. This suggests that the immunoreactivity observed for sperm tails is not a product of PLCZ solubilized within the surrounding medium during sperm processing. Immunoblotting of sperm heads and tails after sonication always yielded a series of bands assumed to be degradation products of the protein (Fig. 6B) ; notably, this was not observed when whole sperm were used (Fig. 1A ).
Equine PLCZ Expressed over the Principal Piece of the Flagellum Is Enzymatically Active
The expression of PLCZ in regions overlying the sperm head is generally considered to be consistent with a physiological role in conferring rapid release of the enzyme at fertilization. Therefore, the finding of PLCZ expression over the principal piece of the flagellum in stallion sperm raised the question of whether this enzyme fraction is catalytically active. To test this, individual sperm heads and tails separated by sonication from a freshly collected ejaculate were injected into mouse oocytes for (Fig. 7) ; conversely, none of the 10 oocytes injected with the medium containing the heads and tails displayed [Ca 2þ ] i responses. In all oocytes injected with sperm heads, [Ca 2þ ] i oscillations lasted for as long as they were monitored (80-140 min); conversely, in 2 of 12 oocytes displaying [Ca 2þ ] i responses after tail injection, oscillations ceased before 1 h following injection. Analysis of the [Ca 2þ ] i oscillations detected between 20 and 30 min after ICSI revealed only a statistically significant difference in the number of spikes (Table 2) . Whereas most oocytes injected with sperm tails appeared to display a lower frequency of [Ca 2þ ] i oscillations (i.e., longer interspike interval) than those injected with sperm heads, the lack of significant differences might have been caused by the great variability in [Ca 2þ ] i responses observed in oocytes injected with sperm tails (Fig. 7 , C and D, and Table 2 ). Nonetheless, the ability of the sperm flagellum to support [Ca 2þ ] i responses is an interesting and novel result and suggests potential diverse physiological functions of PLCZ in sperm.
Immunohistochemistry for PLCZ in Equine Testis Tissue
The stage of spermatogenesis at which PLCZ is first expressed has not been clearly defined. Indirect evidence suggests interspecies differences based upon injection of round spermatids into mouse oocytes and their ability (or inability) to trigger [Ca 2þ ] i oscillations and/or oocyte activation [34] [35] [36] [37] [38] [39] . Immunohistochemistry was performed to characterize the ontogeny of PLCZ protein expression in equine testis tissue CHARACTERIZATION OF EQUINE PHOSPHOLIPASE C ZETA (Fig. 8) . Positive staining was observed in more mature cells of the spermatogenic line, closer to the lumen of the seminiferous tubules, and thus presumed to be at the round spermatid stage (Fig. 8J) . This finding was supported by the fact that PLCZ expression appeared first over a cap representing the developing acrosome. Positive staining for PLCZ was also localized to the head and tails of elongating spermatids and developing sperm (Fig. 8L) , consistent with our immunofluorescence findings in mature sperm (Fig. 5) . No immunostaining was observed in earlier stages of spermatogenesis (cells closer to the basement membrane of the tubules), somatic cells, or in control samples (Fig. 8, A, C, E, G, I , and K).
Round Spermatids from Stallion Testis Express Enzymatically Active PLCZ
To ascertain whether PLCZ expressed in round spermatids (Fig. 8) is catalytically active, the cells isolated from the testis of a mature stallion of proven fertility were injected into mouse oocytes for [Ca 2þ ] i monitoring. Under phase-contrast microscopy, round spermatids were the smallest round cells observed, displaying an eccentric nucleus and a smooth cytoplasm (Fig.  9A) . In contrast, spermatocytes were markedly larger in size, with a granular cytoplasm, and often were binucleated (Fig.  9A) . In total, 6 of 10 mouse oocytes injected with round spermatids displayed [Ca 2þ ] i transients, with an interspike interval of 2.29 6 0.54 min (mean 6 SEM) and an average spike duration of 3.14 6 0.59 min (mean 6 SEM; Fig. 9B ).
Conversely, none of the six oocytes injected with the suspending medium displayed [Ca 2þ ] i responses.
DISCUSSION
Mounting evidence supports the notion that oocyte activation at fertilization is brought about by a factor introduced by the sperm-namely, the testis-specific PLCZ CHARACTERIZATION OF EQUINE PHOSPHOLIPASE C ZETA [8, [13] [14] [15] [16] [17] 40] (for review, see [33] ). Whereas this appears to be a highly conserved mechanism among mammals, speciesspecific differences in PLCZ sequence, activity, and expression have been reported, thus enhancing our knowledge of the molecular mechanisms surrounding fertilization. Herein, we report the sequence and ontogeny of testicular expression and sperm immunolocalization of equine PLCZ. Notably, we show unique species-specific differences in the intrinsic activity and, in particular, in the expression of catalytically active PLCZ in sperm and testis.
The sequence of equine PLCZ reveals a structure similar to those of other PLCZ genes characterized to date, with four EF hand domain motifs, X and Y catalytic domains (separated by a linker region), and a C2 domain [8, 13, [15] [16] [17] . Similarly, sequence alignment with murine and human PLCD4 reveals that equine PLCZ lacks the N-terminal PH domain typical for other PLC isoforms (data not shown). However, despite the seemingly conserved nature of PLCZ between different species, it appears that just small sequence differences are sufficient to markedly affect the activity of the construct in a species-specific manner [13, 41] and, potentially, its ability to support advanced stages of embryonic development. In this regard, we report that microinjection of 1 lg/ll of equine PLCZ cRNA into mouse oocytes is able to induce a significantly higher frequency (;3-fold increase) of [Ca 2þ ] i oscillations than microinjection of the same concentration of murine Plcz cRNA. Whereas differences in the relative expression of each of the two proteins (murine vs. equine) in mouse oocytes, which was not quantified herein, could account for these findings [16] , we assume similar protein expression efficiency given that both equine PLCZ and mouse Plcz cRNA were expressed from the same vector. Moreover, because injected PLCZ cRNA requires transcription once injected into oocytes, the lag time between microinjection and initiation of [Ca 2þ ] i transients is also considered to be an indicator of the intrinsic activity of expressed PLCZ [16, 19, 42] . In this regard, oscillations had started by the beginning of monitoring (i.e., by 20 min postinjection) in 7 of 11 versus 2 of 12 oocytes displaying [Ca 2þ ] i transients and injected with equine PLCZ or murine Plcz cRNA, respectively. These findings corroborate the notion that equine PLCZ possesses higher enzymatic activity than the murine counterpart and support our suspicions based upon the high frequency of [Ca 2þ ] i oscillations previously observed when injecting horse sperm into mouse oocytes [26] . Notably, the equine PLCZ clone shows highest homology with porcine (82.5%), human (82.1%), and bovine (79.4%) PLCZ but only a 71.9% homology with the murine protein. Interestingly, when compared to murine Plcz cRNA, both the human and bovine constructs also display a higher relative intracellular Ca 2þ -releasing activity when their corresponding PLCZ cRNA is microinjected into mouse oocytes [16, 41] .
The species-specific differences in enzymatic activity of PLCZ can probably be attributed to amino acid substitutions in different regions of the sequence. In this regard, the EF hand domains are crucial for the in vivo activity of the protein and for the high sensitivity to basal levels of [Ca 2þ ] i (i.e., median effective concentration ¼ 50-80 nM) displayed by PLCZ [20, 43] . In turn, evidence also suggests that a cluster of basic amino acids in the X-Y linker region may be involved in the anchoring of PLCZ to its substrate, PIP 2 [44] . Moreover, the X-Y linker region may play an important function in the regulation of the specific enzymatic activity of the protein [19, 23] . It has been suggested that in vivo proteolysis on this region may determine a conformational change in the protein, thus facilitating access of the catalytic site to PIP 2 [23] . Interestingly, this is the region of the protein showing most divergence among species; notably, the sequence of the X-Y linker region of equine PLCZ shows greatest similarity with that of the human, bovine, and porcine (49.0%, 48.1%, and 47.4% homology, respectively, vs. 35.4% homology with the mouse), which may account for different relative enzymatic activities displayed by their corresponding proteins.
The present study also reveals unique species-specific differences regarding the expression of PLCZ in sperm and testis. Most notably, we show via immunofluorescence and immunoblotting that PLCZ is expressed in both the head (acrosomal and equatorial regions) and the principal piece of the flagellum in equine sperm. In other species, reported discrepancies in PLCZ localization in sperm have been attributed to the particular antibody used [17, 24, 45] . Whereas we have only tested one anti-PLCZ antibody in the present study and this could account for some of our findings, the fact that injection of sperm flagella into mouse oocytes induced [Ca 2þ ] i oscillations provides direct evidence for the expression of catalytically active protein in this sperm region. To our knowledge, this has not been reported in any other species. Immunofluorescence studies have shown that PLCZ localizes to the equatorial region of bull and human sperm [24, 25] and to the acrosomal and postacrosomal regions of mouse, hamster, and human sperm [17, 25, 45] . Moreover, whereas Fujimoto et al. [45] reported weak PLCZ immunostaining of the flagellum in mouse sperm, it was previously shown that injection of one to three mouse sperm tails failed to induce oocyte activation [46] . In addition, incubation of stallion sperm in capacitating conditions did not alter the pattern of expression of PLCZ, as has been reported for mouse and hamster sperm [17] . However, induction of acrosomal exocytosis did abrogate PLCZ immunostaining over the acrosomal region, as previously shown for all mouse, hamster, and human sperm [17, 25] , suggesting that PLCZ over this sperm region does not contribute to oocyte activation. Altogether, these findings raise the possibility of potential additional physiological functions of the catalytically active PLCZ localized over the acrosome and principal piece of equine sperm.
Species-specific differences have also been noted in the ontogeny of expression of PLCZ in the testis. For instance, in the mouse, rabbit, rat, and pig, round spermatids do not yet express PLCZ [15, [34] [35] [36] [37] [38] [39] 47] , because the expression of the protein is first evident at the elongated spermatid stage [15, 34, 36] . Whereas in the mouse normal offspring have been produced by the injection of these round cells, an additional activation mechanism is necessary to initiate [Ca 2þ ] i rises and, thus, the embryonic development program [34, 36] . Conversely, human-and hamster-derived round spermatids are able to support [Ca 2þ ] i oscillations and, thus, activation when injected into mouse oocytes [35, 48] , thereby supporting the notion that enzymatically active protein is expressed by these cells. Similarly, we show conclusive evidence of catalytically active equine PLCZ expression as early as the round spermatid stage.
In summary, we present a novel sequence for equine PLCZ, which transcribes into a product displaying high intrinsic intracellular Ca 2þ -releasing activity in mouse oocytes. Additionally, we reveal species-specific findings regarding the expression of catalytically active PLCZ in equine sperm and testis. Further studies should be directed at more closely analyzing the specific catalytic activity of the equine clone, with special attention to the regions of the sequence that determine such activity via mutational analysis. It would also be interesting to ascertain the potential physiological relevance of PLCZ expression in the acrosome and principal piece of stallion sperm, because this may be potentially related to other important functions, such as acrosomal exocytosis and/or hyperactivation of motility. We also plan on characterizing the activity of equine PLCZ and ability to support parthenogenetic embryonic development when injected into mare oocytes. 
